E20 - Re-inventing Precision Medicine with AI | Jolly Nanda, Founder and CEO, Altheia, Inc  episode artwork

EPISODE · Feb 9, 2026 · 37 MIN

E20 - Re-inventing Precision Medicine with AI | Jolly Nanda, Founder and CEO, Altheia, Inc

from Life Science Insights 360 Podcasts · host Life Science Insights360

In this episode, we sit down with Jolly Nanda, Founder and CEO of Altheia, Inc., to explore how artificial intelligence is transforming precision medicine from a reactive model into one that is predictive, personalized, and proactive.Jolly shares her entrepreneurial journey and the inspiration behind founding Altheia, highlighting the gaps she observed in traditional precision medicine approaches. While precision medicine has made meaningful progress, much of today’s healthcare system still reacts to disease after symptoms appear. Jolly explains how AI-driven insights are changing that paradigm—unlocking deeper understanding from complex patient data, accelerating diagnostics, and enabling earlier, more targeted interventions.At the core of the conversation is the convergence of AI, clinical data, genomics, and digital health. By integrating multi-omics datasets with real-world clinical information, machine learning models can identify subtle patterns and correlations that would otherwise remain hidden. These insights allow for improved disease prediction, earlier detection, and more individualized therapeutic strategies tailored to each patient’s biological profile.We also discuss the practical realities of building and scaling AI solutions in healthcare. From regulatory and interoperability challenges to adoption within clinical and commercial environments, Jolly outlines the importance of balancing innovation with trust, transparency, and governance. Responsible AI—grounded in ethical frameworks and robust validation—is essential to ensuring that predictive technologies truly serve patients and providers.Episode Highlights:How AI is shifting healthcare from reactive treatment to predictive, preventive careThe power of data-driven personalization in improving patient outcomesInsights into building and scaling an AI-first precision medicine companyThe importance of ethical frameworks, transparency, and responsible AI deploymentA forward-looking vision for AI-enabled, proactive healthcare innovationThis episode offers valuable perspective for healthcare leaders, digital health innovators, biopharma executives, and technologists seeking to understand how AI is reshaping precision medicine—and how predictive intelligence will define the next era of healthcare.

Episode metadata supplied by the publisher feed · Published Feb 9, 2026

Embed this episode

NOW PLAYING

E20 - Re-inventing Precision Medicine with AI | Jolly Nanda, Founder and CEO, Altheia, Inc

0:00 37:21

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Life Science Insights 360 Podcasts?

This episode is 37 minutes long.

When was this Life Science Insights 360 Podcasts episode published?

This episode was published on February 9, 2026.

Can I download this Life Science Insights 360 Podcasts episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!